An Overview of Organ-Specific Autoimmune Diseases Including Immunotherapy

References

• Aaltonen J, Bjorses P, Perheentupa J, et al. (1997). An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet, 17, 399–403
   PubMed Web of Science ®Google Scholar
• Ambery P, Donner TW, Biswas N, et al. (2014). Efficacy and safety of low-dose otelixizumab anti-CD3 monoclonal antibody in preserving C-peptide secretion in adolescent type 1 diabetes: DEFEND-2, a randomized, placebo-controlled, double-blind, multi-centre study. Diabet Med, 31, 399–402
   PubMed Web of Science ®Google Scholar
• Argiles J, Lopez-Soriano J, Lopez-Soriano F. (1994). Cytokines and diabetes: The final step? Involvement of TNF-alpha in both type I and type II diabetes mellitus. Horm Metab Res, 26, 447–9
   PubMed Web of Science ®Google Scholar
• Atkinson MA. (2012). The pathogenesis and natural history of type 1 diabetes. Cold Spring Harb Perspect Med, 2, a007641, 1–18
   Google Scholar
• Bailey-Bucktrout SL, Martinez-Llordella M, Zhou X, et al. (2013). Self-antigen-driven activation induces instability of regulatory T cells during an inflammatory autoimmune response. Immunity, 39, 949–62
   PubMed Web of Science ®Google Scholar
• Berentsen S, Sundic T. (2015). Red blood cell destruction in autoimmune hemolytic anemia: Role of complement and potential new targets for therapy. BioMed Res Int, 2015, 11
   Web of Science ®Google Scholar
• Bluestone JA. (2011). Mechanisms of tolerance. Immunol Rev, 241, 5–19
   PubMed Web of Science ®Google Scholar
• Bratland E, Husebye ES. (2011). Cellular immunity and immunopathology in autoimmune Addison’s disease. Mol Cell Endocrinol, 336, 180–90
   PubMed Web of Science ®Google Scholar
• Cooper GS, Bynum MLK, Somers EC. (2009). Recent insights in the epidemiology of autoimmune diseases: Improved prevalence estimates and understanding of clustering of diseases. J Autoimmuni, 33, 197–207
   PubMed Web of Science ®Google Scholar
• Dabelea D, Mayer-Davis EJ, Saydah S, et al. (2014). Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA, 311, 1778–86
   PubMed Web of Science ®Google Scholar
• Gerber MA, Baltimore RS, Eaton CB, et al. (2009). Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: A scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics. Circulation, 119, 1541–51
   PubMed Web of Science ®Google Scholar
• Keane J, Gershon S, Wise RP, et al. (2001). Tuberculosis associated with infliximab, a tumor necrosis factor α–neutralizing agent. NEngl J Med, 345, 1098–104
   PubMed Web of Science ®Google Scholar
• Knight D, Trinh H, Le J, et al. (1993). Construction and initial characterization of a mouse-human chimeric anti-TNF antibody. Mol Immunol, 30, 1443–53
   Google Scholar
• Kremer JM, Genant HK, Moreland LW, et al. (2006). Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: A randomized trial. Ann Intern Med, 144, 865–76
   PubMed Web of Science ®Google Scholar
• Lee J-H, Slifman NR, Gershon SK, et al. (2002). Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor α antagonists infliximab and etanercept. Arthritis Rheum, 46, 2565–70
   PubMed Web of Science ®Google Scholar
• Maheshwari R, Weis E. (2012). Thyroid associated orbitopathy. Indian J Ophthalmol, 60, 87–93
   PubMed Web of Science ®Google Scholar
• Mastrandrea L, Yu J, Behrens T, et al. (2009). Etanercept treatment in children with new-onset type 1 diabetes: Pilot randomized, placebo-controlled, double-blind study. Diabetes Care, 32, 1244–9
   PubMed Web of Science ®Google Scholar
• McLeod DA, Cooper D. (2012). The incidence and prevalence of thyroid autoimmunity. Endocrine, 42, 252–65
   PubMed Web of Science ®Google Scholar
• Moghadam-Kia S, Werth VP. (2010). Prevention and treatment of systemic glucocorticoid side effects. Int J Dermatol, 49, 239–48
   PubMed Web of Science ®Google Scholar
• O’Garra A, Vieira P. (2004). Regulatory T cells and mechanisms of immune system control. Nat Med, 10, 801–5
   PubMed Web of Science ®Google Scholar
• Orban T, Sosenko JM, Cuthbertson D, et al. (2009). Pancreatic islet autoantibodies as predictors of type 1 diabetes in the diabetes prevention Trial–Type 1. Diabetes Care, 32, 2269–74
   PubMed Web of Science ®Google Scholar
• Ortonne JP. (2003). Clinical response to alefacept: results of a phase 3 study of intramuscular administration of alefacept in patients with chronic plaque psoriasis. J Eur Acad Dermatol Venereol, 17, 12–16
   PubMed Web of Science ®Google Scholar
• Pettitt DJ, Talton J, Dabelea D, et al. (2014). Prevalence of diabetes in U.S. youth in 2009: The SEARCH for diabetes in youth study. Diabetes Care, 37, 402–8
   PubMed Web of Science ®Google Scholar
• Ray S, Sonthalia N, Kundu S, Ganguly S. (2012). Autoimmune disorders: An overview of molecular and cellular basis in today’s perspective. J Clin Cell Immunol, S10, 003
   Google Scholar
• Rigby MR, DiMeglio LA, Rendell MS, et al. (2013). Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Diabetes Endocrinol, 1, 284–94
   PubMed Web of Science ®Google Scholar
• Romi F. (2011). Thymoma in myasthenia gravis: From diagnosis to treatment. Autoimmune Dis, 2011, 474512
   PubMedGoogle Scholar
• Salvi M, Vannucchi G, Currò N, et al. (2015). Efficacy of B-Cell targeted therapy with rituximab in patients with active moderate to severe graves’ orbitopathy: A randomized controlled study. J Clin Endocrinol Metab, 100, 422–31
   PubMed Web of Science ®Google Scholar
• Schwenger V, Morath C. (2010). Immunoadsorption in nephrology and kidney transplantation. Nephrol Dial Transplant, 25, 2407–13
   PubMed Web of Science ®Google Scholar
• Skyler JS, Ricordi C. (2011). Stopping type 1 diabetes: Attempts to prevent or cure type 1 diabetes in man. Diabetes, 60, 1–8
   PubMed Web of Science ®Google Scholar
• Tisch R, Liblau RS, Yang XD, et al. (1998). Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice. Diabetes, 47, 894–9
   PubMed Web of Science ®Google Scholar
• Waldner H. (2009). The role of innate immune responses in autoimmune disease development. Autoimmun Revs, 8, 400–4
   PubMed Web of Science ®Google Scholar
• Wherrett DK, Bundy B, DiMeglio LA, et al. (2011). Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: A randomized double-masked controlled trial. Lancet, 378, 319–27
   PubMed Web of Science ®Google Scholar
• Winthrop KL, Chiller T. (2009). Preventing and treating biologic-associated opportunistic infections. Nat Rev Rheumatol, 5, 405–10
   PubMed Web of Science ®Google Scholar
• Yanaba K, Bouaziz J-D, Matsushita T, et al. (2008). B-lymphocyte contributions to human autoimmune disease. Immunol Rev, 223, 284–99
   PubMed Web of Science ®Google Scholar
• Zhang YY, Tang Z, Chen DM, et al. (2014). Comparison of double filtration plasmapheresis with immunoadsorption therapy in patients with anti-glomerular basement membrane nephritis. BMC Nephrol, 15, 128
   PubMed Web of Science ®Google Scholar